Acta Pharm. 60 (2010) 141–152
Original research paper
DOI: 10.2478/v10007-010-0017-8
Simultaneous spectrophotometric determination of losartan
potassium, amlodipine besilate and hydrochlorothiazide in
pharmaceuticals by chemometric methods
D. NAGAVALLI1,*
V. VAIDHYALINGAM2
A. SANTHA3
A. S. K. SANKAR1
O. DIVYA4
1
Department of Pharmaceutical
Analysis, Adhiparasakthi College
of Pharmacy, Melmaruvathur-603319
Kanchipuram District, Tamil Nadu
India
2
Madras Medical College
Chennai-600003, India
3
C. L. Baid Metha College of Pharmacy
Chennai-600096, Tamil Nadu, India
4
IIT, Chennai-600036, Tamil Nadu
India
In the present work, four different spectrophotometric
methods for simultaneous estimation of losartan potassium, amlodipine besilate and hydrochlorothiazide in raw
materials and in formulations are described. Overlapped
data was quantitatively resolved by using chemometric
methods, classical least squares (CLS), multiple linear regression (MLR), principal component regression (PCR)
and partial least squares (PLS). Calibrations were constructed using the absorption data matrix corresponding to
the concentration data matrix, with measurements in the
range of 230.5–350.4 nm (Dl = 0.1 nm) in their zero order
spectra. The linearity range was found to be 8–40, 1–5 and
3–15 mg mL–1 for losartan potassium, amlodipine besilate and hydrochlorothiazide, respectively. The validity
of the proposed methods was successfully assessed for
analyses of drugs in the various prepared physical mixtures and in tablet formulations.
Keywords: losartan potassium, amlodipine besilate, hydrochlorothiazide, spectrophotometry, chemometry
Accepted February 16, 2010
Losartan potassium (LOS), amlodipine besilate (AML) and hydrochlorothiazide
(HYD) are drugs widely used for the treatment of hypertension and cardiovascular diseases in combined pharmaceutical preparations. Losartan potassium and its principal
active metabolites block the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively blocking the binding of angiotensin II to angiotensin II receptor
type 1 (AT1) receptor found in many tissues (vascular smooth muscle, adrenal gland).
Amlodipine besilate inhibits the movement of calcium ions across the cell membrane
into vascular smooth muscles and myocytes. Action is stronger in arterial resistance vessels causing peripheral vasodilatation and reduction in afterload. Hydrochlorothiazide
inhibits the reabsorption of sodium and chloride at the beginning of the distal convo* Correspondence; e-mail: d_nagavalli@yahoo.co.in
141
D. Nagavalli et al.: Simultaneous spectrophotometric determination of losartan potassium, amlodipine besilate and hydrochlorothiazide in
pharmaceuticals by chemometric methods, Acta Pharm. 60 (2010) 141–152.
luted tubule. It causes natriuretic effect mainly by decreasing sodium and chloride reabsorption in the cortical segment of the ascending limb of the loop of Henley by inhibition of a specific Na+,Cl– co-transporter (1).
A few estimations in body fluids, in bulk in combination with other drugs and in
single dosage forms have been reported for losartan potassium, amlodipine besilate and
hydrochlorothiazide such as HPLC (2–7), spectrophotometry (8), multivariate approach
(9), multi-syringe chromatography (MSC) (10) and HPTLC (11, 12), ultra performance
liquid chromatography (UPLC-MS) (13). All these drugs are available in combined tablet dosage forms, as antihypertensive agents. An extensive literature survey revealed
that a number of methods are reported for the individual drugs but there is no report on
simultaneous estimation of such a combination in physical mixtures or in pharmaceutical formulations by chemometric methods. The present article discusses the attempts
made to develop simple, sensitive and reproducible methods for simultaneous estimation of these drugs in dosage forms.
Chemometric calibration techniques in spectral analysis are widely used in the
quality control of drugs in mixtures and pharmaceutical formulations containing two or
more drugs with overlapping spectra where separation procedures are not required in
drug determination. We have also used these techniques for simultaneous analyses of
mixtures (14–19).
In this study, four chemometric methods for spectral data processing are proposed
for simultaneous determination of LOS, AML and HYD in their ternary mixtures and in
tablets.
EXPERIMENTAL
Instrument and software
A Shimadzu (Japan) 2550-double beam spectrophotometer was used for all spectrophotometric measurements. Absorption spectra of the reference and test solutions were
taken in 1-cm matched quartz cells over the range of 200–400 nm. Chemometric calculations on the resulting data were carried out with the PLS toolbox (Demover5.0) in
MATLAB 7 (Math works).
Samples and solvents
Losartan potassium, amlodipine besilate and hydrochlorothiazide were kindly supplied by ATOZ India Ltd., India, and were certified to be 99.8, 99.6 and 99.9 % pure, respectively. The drugs were used without further purification. All the solvents used in
spectrophotometric analysis were of analytical reagent grade. Trilopace tablets, batch
number BF 70002 (Akums Drugs & Pharmaceuticals Ltd., India), which were claimed to
contain 50 mg of losartan potassium USP, 5 mg of amlodipine besilate BP and 12.5 mg of
hydrochlorothiazide IP, were used.
142
D. Nagavalli et al.: Simultaneous spectrophotometric determination of losartan potassium, amlodipine besilate and hydrochlorothiazide in
pharmaceuticals by chemometric methods, Acta Pharm. 60 (2010) 141–152.
Standard solutions and mixtures
Stock solutions of LOS (1 mg mL–1), AML (1 mg mL–1) and HYD (2 mg mL–1) in
methanol were diluted with water to prepare the working solutions (0.16 mg mL–1, 0.02
mg mL–1 and 0.06 mg mL–1, respectively). The calibration set contained 25 and the prediction set 9 mixtures of calibration samples, so that the concentration of each drug in
the resulting solutions was in its own linear dynamic range, as shown in Table 1. Furthermore, we demonstrated that in formulations LOS, AML and HYD range 1: 2.5: 10.
Tablet analysis
Twenty tablets were weighed accurately and powdered. An amount of the powder
equivalent to 50 mg of AML, 125 mg of HYD and 500 mg of LOS was dissolved in 50 mL
of methanol. The solution was ultrasonicated for 10 minutes. Then, the solution was filtered through Whatman filter paper No. 41. The filtrate (3 mL) was transferred into a
100 mL volumetric flask and made up to volume with Millipore water. Aliquots of these
solutions were used in such a way that the concentration of each drug was within the
range of the calibration matrix. The diluted solutions were analyzed six times. All the
proposed chemometric methods were applied.
Chemometric methods
Classical least squares (CLS). – This method assumes Beer’s law model with the
absorbance at each frequency being proportional to the component concentration. In
Table I. Composition of the calibration set
Concentration (mg mL–1)
Concentration (mg mL–1)
Mixture
LOS
AML
HYD
Mixture
LOS
AML
HYD
1
24
3
9
14
24
5
15
2
24
1
3
15
40
5
3
3
8
1
15
16
40
1
12
4
8
5
6
17
8
4
3
5
40
2
15
18
32
1
9
6
16
5
9
19
8
3
12
7
40
3
6
20
24
4
12
8
24
2
6
21
32
4
6
9
16
2
12
22
32
2
3
10
16
4
15
23
16
1
6
11
32
5
12
24
8
2
9
12
40
4
9
25
16
3
3
13
32
3
15
LOS, AML, HYD – losartan potassium, amlodipine besilate, hydrochlorothiazide, respectively.
143
D. Nagavalli et al.: Simultaneous spectrophotometric determination of losartan potassium, amlodipine besilate and hydrochlorothiazide in
pharmaceuticals by chemometric methods, Acta Pharm. 60 (2010) 141–152.
matrix notation, Beer’s law model for m calibration standards containing l chemical
components with the spectra of n digitized absorbances is given by:
A = C ´ K + EA
(1)
where A is the m ´ n matrix of calibration spectra, C is the m ´ l matrix of component
concentration, K is the l ´ n matrix of absorptivity-path length products, and EA is the
m ´ n matrix of spectral errors. K then represents the matrix of pure component spectra
at unit path length. The classical least squares solution according to Eq. (1) during calibration is:
K$ = (CT C)−1 CT × A
(2)
where K$ indicates the least-squares estimation of K.
Analysis based on spectrum a, of unknown component concentration (sample):
$ $ T )−1 K$ × a
C0 = (KK
(3)
$
where C0 is vector of predicted concentration and K$ T is the transpose of matrix K.
Multiple linear regressions (MLR). – If absorbance measurements for several solutions
containing mixtures of the analytes are made in numbers exceeding the number of mixture components, then the system composed of the absorbance and concentration matrices will be overdimensioned and take the following matrix form:
A = KC
(4)
where A is the data absorbance calibration matrix, K is the matrix from which the proportionality constants are calculated from spectra for standard solutions of pure analytes and/or their mixtures, and C is the concentration matrix. The C prediction concentration matrix can be calculated from the following equation:
C = (KTK)–1 KT
(5)
where K’ is the transpose of K and A is the absorbance matrix of unknown samples. Matrix K can be obtained in various ways. We calculated K values by MLR of the data for
mixtures of analytes of known composition (20).
Principle component regression (PCR). – In the spectral work, the following steps can
explain the fundamental concept of PCR. The original data obtained in absorbances (A)
and concentrations (C) of analytes were reprocessed by mean-centring as A0 and C0, respectively. Using the ordinary linear regression:
C=a+b´A
144
(6)
D. Nagavalli et al.: Simultaneous spectrophotometric determination of losartan potassium, amlodipine besilate and hydrochlorothiazide in
pharmaceuticals by chemometric methods, Acta Pharm. 60 (2010) 141–152.
The coefficient b is: b = P ´ q, where P is the matrix of eigenvectors and q is the
C-loadings given by q = D ´ TT ´ A0. Here, TT is the transpose of the score matrix T. D is
a diagonal matrix having on components the inverse of the selected eigenvalues.
Knowing b one can easily find a by using the formula a = Cmean ´ ATmean ´ b, where
ATmean represents the transpose of the matrix having the entries of the mean absorbance
values, and Cmean is the mean concentration of the calibration set.
Partial least squares (PLS). – In the UV-Vis spectra, the absorbance data (A) and concentration data (C) are mean centered to give the data matrix A0 and vector C0. The
orthogonalized PLS algorithm has the following steps. The loading weight vector W has
the following expression:
A0T C0
C0T C0
(7)
A0W
A0T t1
(8)
P1 = t1T t1
(9)
C0T t1
t1T t1
(10)
W=
The scores and loadings are given by:
t1 =
q1 =
The matrix and vector of the residuals in A0 and C0 are:
A1 = A0 − t1 P1T
(11)
C1 = C0 − t1 q1T
(12)
From the general linear equation, the regression coefficients were calculated by:
b = W(PTW)-1q
(13)
a = Cmean – ATmeanb
(14)
The built calibration equation is used for the estimation of the compounds in the
samples (21).
145
D. Nagavalli et al.: Simultaneous spectrophotometric determination of losartan potassium, amlodipine besilate and hydrochlorothiazide in
pharmaceuticals by chemometric methods, Acta Pharm. 60 (2010) 141–152.
RESULTS AND DISCUSSION
A calibration set was randomly prepared as mixtures of LOS, AML and HYD in
their possible compositions by applying a multilevel multifactor design (22) (Table I).
The UV absorbance data were obtained by measuring the absorbances in the region of
200–400 nm (Fig. 1). From this 230.5–350.4 nm wavelength was selected for construction
5
4.5
4
–1
Absorbance
3.5
Amlodipine besilate (5 mg mL )
–1
3
Hydrochlorothiazide (15 mg mL )
2.5
–1
Losartan potassium (40 mg mL )
2
1.5
1
0.5
0
200
Fig. 1. Overlapping spectrum of LOS, AML
and HYD.
220
240
260
280
300
320
340
360
380
400
Wavelenght (nm)
Table II. Statistical parameters of chemometric methods in the calibration set
Method
CLS
Parameter
0.1823
0.1647
0.1183
0.1264
0.0908
0.1110
1
0.9940
0.9990
RMSECV
0.2258
0.2047
0.2583
RMSEP
0.2062
0.0908
0.2328
1
0.9920
0.9980
RMSEC
0.1647
0.1183
0.1823
RMSECV
0.1987
0.1424
0.2134
RMSEP
0.1250
0.0856
0.1120
1
0.9940
0.9990
R
PLS
HYD
RMSEP
R
PCR
AML
RMSECV
R
MLR
LOS
RMSEC
0.1647
0.1183
0.1823
RMSECV
0.1987
0.1424
0.2134
RMSEP
0.1250
0.0856
0.1120
1
0.9940
0.9990
R
CLS – classical least squares, MLR – multiple linear regression, PCR – principal component regression.
PLS – partial least squares, RMSEP – root mean square error of prediction, RMSECV – root mean square error
of cross validation, RMSEC – root mean square error of calibration.
For other acronyms see Table I.
146
D. Nagavalli et al.: Simultaneous spectrophotometric determination of losartan potassium, amlodipine besilate and hydrochlorothiazide in
pharmaceuticals by chemometric methods, Acta Pharm. 60 (2010) 141–152.
of the calibration model. The fit model was constructed by using the absorption data
matrix corresponding to the concentration data matrix in CLS, MLR, PCR and PLS.
Before constructing the model, pre-processing (23) was carried out to reduce the effect of noise, improve the predictive ability of the model and simplify the model by making the data more normally distributed and the wavelength selection based on the best
outcome for reduced error of spectral data. In Table II, R is defined as the correlation coefficient between constituent concentrations and shows the absorbance effects relating to
the constituent of interest. Values obtained in the methods close to 1 mean no interference was coming from other constituents in the respective set of calibration mixtures.
The most commonly employed validation criterion is to divide the dataset into two
subsets, a calibration set and a validation set. The calibration model is calculated using
the calibration set. Then, the root mean square errors of calibration and validation,
RMSEC – root mean square error of calibration and RMSECV – root mean square error
of cross validation, are calculated by using the calibration model under investigation to
predict the samples in the calibration set and validation set, respectively:
RMSEC =
(y − y pred )i (y − y pred )
m −1
Selection of the optimum number of factors for PCR and PLS. – For PCR and PLS methods, 25 calibration spectra were used for the selection of the optimum number of factors
by using the cross-validation with the leave-out-one technique. This allows modelling of
the system with the optimum amount of information and avoidance of over-fitting or
under-fitting. The cross-validation procedure consisted of systematically removing one
of a group of training samples in turn and using only the remaining ones for the construction of latent variable factors and applied regression. The predicted concentrations
were then compared with the actual ones for each of the calibration samples and the
root mean square error of prediction (RMSEP) was calculated. The RMSEP was computed in the same manner each time, and then a new factor was added to the PCR and PLS
model. The selected model was that with the smallest number of factors such that its
PCR variance captured
RMSECV 1, RMSECV 2, RMSECV 3
12
RMSECV 1
RMSECV 2
RMSECV 3
10
8
6
4
2
0
2
4
6
8
10
12
14
16
Principal component number
18
20
Fig. 2. Representation of RMSECV values
generated from calibration by PCR: LOS,
AML and HYD.
147
D. Nagavalli et al.: Simultaneous spectrophotometric determination of losartan potassium, amlodipine besilate and hydrochlorothiazide in
pharmaceuticals by chemometric methods, Acta Pharm. 60 (2010) 141–152.
10 SIMPLS variance captured
RMSECV 1
RMSECV 2
RMSECV 3
RMSECV 1, RMSECV 2, RMSECV 3
9
8
7
6
5
4
3
2
1
Fig. 3. Representation of RMSECV values
generated from calibration by PLS: LOS,
AML and HYD.
0
2
4
6
8
10
12
14
Latent variable number
16
18
20
RMSECV values were not significantly greater than that for the model, which yielded
the minimum RMSECV. A plot of RMSECV values against the number of components
(Figs. 2 and 3) indicates that the latent variable factor 3 was optimum for PCR and PLS
selected based on the RMSEC and RMSECV, respectively, for the estimation of the titled
drugs. At the selected principal component of PCR and PLS, the concentrations of each
sample was then predicted and compared with the known concentration and the RMSEP
was calculated:
N
RMSEC =
∑
(y ipred − y iref )2
i=y
RMSEC =
N
(y − y pred )i (y − y pred )
m −1
Table III. Composition of synthetic mixtures (formulation) and recovery set
Synthetic formulation (mg mL–1)a
Formulation (mg mL–1)b
Recovery (mg mL–1)c
LOS
AML
HYD
LOS
AML
HYD
LOS
AML
24.8
3.6
10.8
30
3
7.5
3
0.45
HYD
0.75
24.8
1.2
3.6
30
3
7.5
3
0.45
0.75
9.6
1.2
18.0
30
3
7.5
3
0.45
0.75
9.6
6.0
7.2
30
3
7.5
6
0.90
1.50
48.0
2.4
18.0
30
3
7.5
6
0.90
1.50
19.2
6.0
10.8
30
3
7.5
6
0.90
1.50
48.0
3.6
7.2
30
3
7.5
9
1.35
2.25
28.8
2.4
7.2
30
3
7.5
9
1.35
2.25
19.2
2.4
14.4
30
3
7.5
9
1.35
2.25
a
Synthetic mixture of LOS, AML and HYD (standards).
Pharmaceutical formulation, tablet.
c Recovery – standard addition to pharmaceutical formulation..
For other acronyms see Table I.
b
148
D. Nagavalli et al.: Simultaneous spectrophotometric determination of losartan potassium, amlodipine besilate and hydrochlorothiazide in
pharmaceuticals by chemometric methods, Acta Pharm. 60 (2010) 141–152.
Table IV. Prediction results for losartan, amlodipine and hydrochlorothiazide from the synthetic validation
samples by different chemometric methods
CLS
Component
Mean ±
LOS
MLR
SDa
100.6
Mean ±
0.9
100.4
PCR
SDa
1.2
Mean ±
100.6
PLS
SDa
0.9
Mean ± SDa
100.6
0.9
AML
100.0
1.6
100.6
0.7
100.0
0.5
100.0
0.5
HYD
100.9
0.6
99.7
0.9
100.9
0.7
100.9
0.7
a
Nine determinations.
For acronyms see Table I and II.
In order to test the proposed techniques, the validation set of synthetic mixtures
(from standards) containing the three drugs (Table III) in variable ratios was carried out;
the results are given in Table IV. The maximum values of the mean percent errors corresponding to CLS, MLR, and PCR and PLS for the same mixtures were completely acceptable because of their very small numerical values (below 0.2). Results of tablet analyses are shown in Table V.
Recovery and precision studies
To check the validity of the proposed methods, recovery studies were carried out by
addition of the standard to the preanalyzed formulation. Results of recovery studies were
found to be from 99.3 ± 0.3 to 101.3 ± 0.6 % (Table VI). Good precision of the method was
indicated by RSD ranging 0.3–1.4 %.
Table V. Prediction results for losartan, amlodipine and hydrochlorothiazide in formulation samples by
different chemometric methods
Method
CLS
MLR
PCR
PLS
a
Parametera
LOS
AML
HYD
Mean (%)
100.02
100.39
101.28
RSD (%)
0.034
0.720
0.131
Mean (%)
100.27
98.92
101.52
RSD (%)
0.078
1.683
1.192
Mean (%)
100.01
100.36
101.32
RSD (%)
0.033
0.705
0.128
Mean (%)
100.01
100.36
101.32
RSD (%)
0.033
0.705
0.128
Nine determinations.
149
D. Nagavalli et al.: Simultaneous spectrophotometric determination of losartan potassium, amlodipine besilate and hydrochlorothiazide in
pharmaceuticals by chemometric methods, Acta Pharm. 60 (2010) 141–152.
Table VI. Recovery studies of LOS, AML and HYD in pharmaceutical formulationsa
LOS
AML
HYD
Method Added
Found *Recovery
Found *Recovery Added
Found
Recovery Added
(%)b
(%)b
(mg mL–1) (mg mL–1)
(mg mL–1) (mg mL–1)
(mg mL–1) (mg mL–1) (%)b
CLS
3
33.1
100.4
0.5
3.4
99.8
0.8
8.4
101.6
6
36.0
100.0
0.9
3.9
99.2
1.5
9.1
100.6
9
39.0
100.1
1.4
4.3
99.4
2.3
9.9
101.6
Mean
100.1
S.D
MLR
± 0.2
33.0
6
35.7
99.3
0.9
9
39.1
100.2
1.4
3.5
± 0.6
101.3
0.8
8.4
102.2
3.9
99.9
1.5
9.1
100.6
4.4
100.5
2.3
9.8
100.5
± 0.7
100.3
101.0
± 1.0
± 1.4
3
33.1
100.3
0.5
3.4
99.8
0.8
8.4
101.7
6
36.0
100.0
0.9
3.9
99.0
1.5
9.1
100.6
9
39.0
100.0
1.4
4.3
99.2
2.3
9.9
101.6
Mean
100.1
99.3
S.D
± 0.2
± 0.4
PLS
a
0.5
99.9
S.D
b
100.1
101.3
± 0.3
3
Mean
PCR
99.5
101.3
± 0.6
3
33.1
100.3
0.5
3.4
99.7
0.8
8.4
101.7
6
36.0
100.0
0.9
3.9
99.0
1.5
9.1
100.6
9
39.0
100.0
1.4
4.3
99.2
2.3
9.9
101.6
Mean
100.1
99.3
101.3
S.D
± 0.2
± 0.4
± 0.6
Additions to 30 mg mL–1 LOS, 3 mg mL–1 AML and 7.5 mg mL–1 HYD in the formulation.
Nine determinations.
CONCLUSIONS
Based on the results obtained in this work, the UV spectrophotometric method for
simultaneous determination of losartan potassium, amlodipine besilate and hydrochlorothiazide in mixtures by multivariate calibration of synthetic and pharmaceutical samples is applicable. PLS and PCR using a calibration matrix constructed with absorption
spectra were successfully applied to simultaneous analysis of these drugs in synthetic
and pharmaceutical mixtures.
Acknowledgements. – One of the authors, Mrs. D. Nagavalli, gratefully acknowledges
the support from the management of Adhiparasakthi Medical and Charitable Trust, Melmaruvathur, in providing necessary facilities to carry out this research work. Orchid
(Chemicals & Pharmaceuticals, Ltd, R&D division, Chennai, and Prof Dr. A. K. Mishra,
IIT, Chennai) are kindly acknowledged for allowing to use their facilities.
150
D. Nagavalli et al.: Simultaneous spectrophotometric determination of losartan potassium, amlodipine besilate and hydrochlorothiazide in
pharmaceuticals by chemometric methods, Acta Pharm. 60 (2010) 141–152.
REFERENCES
1. Merck Index, 14th ed., Merck and Co. Inc., White House Station 2003.
2. N. Erk, Analysis of binary mixtures of losartan potassium and hydrochlorothiazide by using
high performance liquid chromatography, ratio derivative spectrophotometric and compensation technique, J. Pharm. Biomed. Anal. 24 (2001) 603–611.
3. D. L. Hertzog, J. F. McCafferty, X. Fang, R. J. Tyrrell, R. A. Reed, Development and validation of
a stability-indicating HPLC method for the simultaneous determination of losartan potassium,
hydrochlorothiazide, and their degradation products, J. Pharm. Biomed. Anal. 30 (2002) 747–760.
4. M. Polinko, K. Riffel, S. Hengchang and L. O. Man-Wai, Simultaneous determination of losartan
and EXP3174 in human plasma and urine utilizing liquid chromatography/tandem mass spectrometry, J. Pharm. Biomed. Anal. 33 (2003) 73–84; DOI:10.1016/S0731-7085(03)00348-0.
5. R. K. Barman, M. A. Islam, M. Ahmed, M. I. Ibnewahed, R. Islam, A. Khan, M. B. Hossain and
B. M. Rahman, Simultaneous high-performance liquid chromatographic determination of
atenolol and amlodipine in pharmaceutical-dosage form, Pak. J. Pharm. Sci. 20 (2007) 274–279.
6. M. D. Malesuik, S. G. Cardoso, L. Bajerski and F. A. Lanzanova, Determination of amlodipine in
pharmaceutical dosage forms by liquid chromatography and ultraviolet spectrophotometry,
J. AOAC Int. 89 (2006) 359–364.
7. F. Belal, I. A. Al-Zaagi, E. A. Gadkariem and M. A. Abounassif, A stability-indicating LC
method for the simultaneous determination of ramipril and hydrochlorothiazide in dosage
forms, J. Pharm. Biomed. Anal. 24 (2001) 335–342.
8. O. C. Lastra, I. G. Lemus, H. J. Sánchez and R. F. Pérez, Development and validation of a UV
derivative spectrophotometric determination of losartan potassium in tablets, J. Pharm. Biomed.
Anal. 33 (2003) 175–180.
9. M. C. Ferro, P. M. Castellano and T. S. Kaufman, Simultaneous determination of amiloride hydrochloride and hydrochlorothiazide in synthetic samples and pharmaceutical formulations by
multivariate analysis of spectrophotometric data, J. Pharm. Biomed. Anal. 30 (2002) 1121–1131.
10. M. A. Obando, J. M. Estela and V. Cerda, Simultaneous determination of hydrochlorothiazide
and losartan potassium in tablets by high-performance low-pressure chromatography using a
multi-syringe burette coupled to a monolithic column, Anal. Bioanal. Chem. 391 (2008) 2349–2356.
11. S. A. Shah, I. S. Rathod, B. N. Suhagia, S. S. Savale and J. B. Patel, Simultaneous determination
of losartan and hydrochlorothiazide in combined dosage forms by first-derivative spectroscopy
and high-performance thin-layer chromatography, J. AOAC Int. 84 (2001) 1715–1723.
12. R. B. Kakde, V. H. Kotak and D. L. Kale, High performance thin layer chromatographic method
for simultaneous estimation of amlodipine besilate and bisoprolol fumarate in pharmaceutical
preparations, Pharma Rev. Dec-2008, 168–170.
13. Y. Ma, F. Qin, X. Sun, X. Lu and F. Li, Determination and pharmacokinetic study of amlodipine
in human plasma by ultra performance liquid chromatography-electrospray ionization mass
spectrometry, J. Pharm. Biomed. Anal. 43 (2007) 1540–1545.
14. R. Kramer, Chemometric Techniques in Quantitative Analysis, Marcel Dekker, New York 1998.
15. H. Martens and T. Naes, Multivariate Calibration, Wiley, New York 1989.
16. E. Dinç and A. Ozdemir, Linear regression analysis and its application to multivariate chromatographic calibration for the quantitative analysis of two-component mixtures, Farmaco 60 (2005)
591–597.
17. R. Brereton, Chemometrics. Data Analysis for the Laboratory and Chemical Plant, Wiley, Chichester
2003.
18. R. Bro, Håndbog i Multivariabel Kalibrering, Jordbrugsforlaget, Copenhagen, 1996.
151
D. Nagavalli et al.: Simultaneous spectrophotometric determination of losartan potassium, amlodipine besilate and hydrochlorothiazide in
pharmaceuticals by chemometric methods, Acta Pharm. 60 (2010) 141–152.
19. E. Dinç and D. Baleanu, Spectrophotometric quantitative determination of cilazapril and hydrochlorothiazide in tablets by chemometric methods, J. Pharm. Biomed. Anal. 30 (2002) 715–723.
20. Nagaraj, K. Vipul and M. Rajshree, Simultaneous quantitative resolution of atorvastatin calcium
and fenofibrate in pharmaceutical preparation by using derivative ratio spectrophotometry and
chemometric calibrations, Anal. Sci. 23 (2007) 445–451; DOI: 10.2116/analsci.23.445.
21. I. M. Palabiyik, E. Dinç and F. Onur, Simultaneous spectrophotometric determination of pseudoephedrine hydrochloride and ibuprofen in a pharmaceutical preparation using ratio spectra
derivative spectrophotometry and multivariate calibration techniques, J. Pharm. Biomed. Anal.
34 (2004) 473–483.
22. R. G. Brereton, Multilevel multifactor designs for multivariate calibration, Analyst 122 (1997)
1521–1529.
23. G. R. Flåten and A. D. Walmsley, Using design of experiments to select optimum calibration
model parameters, Analyst 128 (2003) 935–943; DOI: 10.1039/b301555f.
S A @ E TA K
Istodobno spektrofotometrijsko odre|ivanje losartan kalija, amlodipin besilata
i hidroklorotiazida u farmaceutskim pripravcima kemometrijskom metodom
D. NAGAVALLI, V. VAIDHYALINGAM, A. SANTHA, A. S. K.SANKAR i O. DIVYA
U radu su opisane ~etiri spektrofotometrijske metode za istodobno odre|ivanje losartan kalija, amlodipin besilata i hidroklorotiazida u sirovinama i farmaceutskim pripravcima. Podaci koji su se preklapali kvantitativno su razlu~eni kemometrijskim metodama, klasi~nom metodom najmanjih kvadrata (CLS), multiplom linearnom regresijom
(MLR), regresijom glavnih komponenata (PCR) te metodom parcijalnih najmanjih kvadrata (PLS). Kalibracije su provedene koriste}i podatke o ovisnosti apsorpcije o koncentracijama, mjere}i spektre nultog reda u rasponu 230,5–350,4 nm (Dl = 0,1 nm). Linearnost za losartan kalij bila je 8–40, za amlodipin besilat 1–5, a za hidroklorotiazid
3–15 mg mL–1. Valjanost predlo`enih metoda uspje{no je potvr|ena analizom navedenih
lijekova u razli~itim pripremljenim smjesama i tabletama.
Klju~ne rije~i: losartan, amlodipin besilat, hidroklorotiazid, spektrofotometrija, kemometrija
Department of Pharmaceutical Analysis, Adhiparasakthi College of Pharmacy, Melmaruvathur-603319,
Kanchipuram District, Tamil Nadu, India
Madras Medical College, Chennai-600003, India
C. L. Baid Metha College of Pharmacy, Chennai-600 096, Tamil Nadu, India
IIT, Chennai-600036, Tamil Nadu, India
152